Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED10x Genomics, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 2 | -$0.53 | -$0.48 | -$0.50 |
| Q2 2024 | 2 | -$0.51 | -$0.46 | -$0.48 |
| Q3 2024 | 3 | -$0.35 | -$0.32 | -$0.33 |
| Q4 2024 | 5 | -$0.38 | -$0.23 | -$0.31 |
| Q1 2025 | 3 | -$0.46 | -$0.30 | -$0.39 |
| Q2 2025 | 2 | -$0.36 | -$0.33 | -$0.34 |
| Q3 2025 | 2 | -$0.29 | -$0.26 | -$0.27 |
| Q4 2025 | 2 | -$0.26 | -$0.23 | -$0.24 |
| Q1 2026 | 1 | -$0.41 | -$0.37 | -$0.39 |
| Q2 2026 | 1 | -$0.35 | -$0.32 | -$0.33 |
| Q3 2026 | 1 | -$0.28 | -$0.25 | -$0.26 |
| Q4 2026 | 1 | -$0.25 | -$0.23 | -$0.24 |
10x Genomics, Inc. Earnings Date And Information
10x Genomics, Inc. last posted its earnings results on Tuesday, October 29th, 2024. The company reported $-0.3 earnings per share for the quarter, topping analysts' consensus estimates of $-0.34 by $0.04. The company had revenue of 151.65 M for the quarter and had revenue of 618.73 M for the year. 10x Genomics, Inc. has generated $-2 earnings per share over the last year ($-2.18 diluted earnings per share) and currently has a price-to-earnings ratio of -9.81. 10x Genomics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 13th, 2025 based on prior year's report dates.
10x Genomics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 10/29/2024 | Q3 2024 | -$0.34 | -$0.30 | 0.04 | $156.89 M | $151.65 M |
| 08/08/2024 | Q2 2024 | -$0.47 | -$0.32 | 0.15 | $150.08 M | $153.10 M |
| 04/30/2024 | Q1 2024 | -$0.46 | -$0.50 | -0.04 | $141.01 M | |
| 02/15/2024 | Q4 2023 | -$0.36 | -$0.41 | -0.05 | $183.98 M | |
| 11/02/2023 | Q3 2023 | -$0.79 | $151.30 M | $153.64 M | ||
| 08/03/2023 | Q2 2023 | -$0.53 | $139.97 M | $146.82 M | ||
| 05/04/2023 | Q1 2023 | -$0.44 | $134.29 M | |||
| 02/16/2023 | Q4 2022 | -$0.15 | $156.23 M | |||
| 11/02/2022 | Q3 2022 | -$0.37 | $128.96 M | $131.07 M | ||
| 08/08/2022 | Q2 2022 | -$0.57 | $115.70 M | $114.61 M | ||
| 05/05/2022 | Q1 2022 | -$0.38 | $114.50 M | |||
| 02/18/2022 | Q4 2021 | -$0.16 | $143.53 M | |||
| 11/05/2021 | Q3 2021 | -$0.15 | $122.56 M | $125.30 M | ||
| 08/06/2021 | Q2 2021 | -$0.10 | $112.85 M | $115.84 M | ||
| 05/07/2021 | Q1 2021 | -$0.11 | $105.82 M | |||
| 02/26/2021 | Q4 2020 | -$3.87 | $112.22 M | |||
| 11/12/2020 | Q3 2020 | -$0.65 | $61.19 M | $71.82 M | ||
| 08/12/2020 | Q2 2020 | -$0.41 | $32.56 M | $42.91 M | ||
| 05/12/2020 | Q1 2020 | -$0.22 | $71.91 M | |||
| 02/27/2020 | Q4 2019 | -$0.07 | $75.29 M |
10x Genomics, Inc. Earnings: FAQ's
When is 10x Genomics, Inc.'s earnings date?
10x Genomics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 13th, 2025 based off last year's report dates.
Did 10x Genomics, Inc. beat their earnings estimates last
quarter?
In the previous quarter, 10x Genomics, Inc. (:TXG) reported $-0.3 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.34 by $0.04.
How can I listen to 10x Genomics, Inc.'s earnings conference
call?
The conference call for 10x Genomics, Inc.'s latest earnings report can be listened to online.
How can I read 10x Genomics, Inc.'s conference call transcript?
The conference call transcript for 10x Genomics, Inc.'s latest earnings report can be read online.
How much revenue does 10x Genomics, Inc. generate each year?
10x Genomics, Inc. (:TXG) has a recorded annual revenue of $618.73 M.
How much profit does 10x Genomics, Inc. generate each year?
10x Genomics, Inc. (:TXG) has a recorded net income of $618.73 M. 10x Genomics, Inc. has generated $-2.18 earnings per share over the last four quarters.
What is 10x Genomics, Inc.'s price-to-earnings ratio?
10x Genomics, Inc. (:TXG) has a price-to-earnings ratio of -9.81 and price/earnings-to-growth ratio is -0.4.